53 related articles for article (PubMed ID: 35708078)
1. Genome-Wide CRISPR-Cas9 Screening and Identification of Potential Genes Promoting Prostate Cancer Growth and Metastasis.
Wang W; Yuan D; Jiang K; Li R; Qu H; Jiang FN; Zhong WD; Sun F; Jia Z; Zhu J
Curr Cancer Drug Targets; 2022; 23(1):71-86. PubMed ID: 35708078
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Gene Editing by CRISPR-Cas9 of miR-21 and the Indirect Target MMP9 in Metastatic Prostate Cancer.
Camargo JA; Viana NI; Pimenta R; Guimarães VR; Dos Santos GA; Candido P; Ghazarian V; Romão P; Silva IA; Birbrair A; Srougi M; Nahas WC; Leite KR; Trarbach EB; Reis ST
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834295
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis.
Chen S; Sanjana NE; Zheng K; Shalem O; Lee K; Shi X; Scott DA; Song J; Pan JQ; Weissleder R; Lee H; Zhang F; Sharp PA
Cell; 2015 Mar; 160(6):1246-60. PubMed ID: 25748654
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel essential gene in prostate cancer metastasis.
Rodrigo-Faus M; Vincelle-Nieto A; Vidal N; Puente J; Saiz-Pardo M; Lopez-Garcia A; Mendiburu-Eliçabe M; Palao N; Baquero C; Linzoain-Agos P; Cuesta AM; Qu HQ; Hakonarson H; Musteanu M; Reyes-Palomares A; Porras A; Bragado P; Gutierrez-Uzquiza A
Cancer Lett; 2024 Apr; 588():216776. PubMed ID: 38432581
[TBL] [Abstract][Full Text] [Related]
5. EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities.
Yedier-Bayram O; Gokbayrak B; Kayabolen A; Aksu AC; Cavga AD; Cingöz A; Kala EY; Karabiyik G; Günsay R; Esin B; Morova T; Uyulur F; Syed H; Philpott M; Cribbs AP; Kung SHY; Lack NA; Onder TT; Bagci-Onder T
Cell Death Dis; 2022 Aug; 13(8):710. PubMed ID: 35973998
[TBL] [Abstract][Full Text] [Related]
6. In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis.
Arriaga JM; Ronaldson-Bouchard K; Picech F; Nunes de Almeida F; Afari S; Chhouri H; Vunjak-Novakovic G; Abate-Shen C
Oncogene; 2024 Apr; 43(17):1303-1315. PubMed ID: 38454137
[TBL] [Abstract][Full Text] [Related]
7. Correction: In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis.
Arriaga JM; Ronaldson-Bouchard K; Picech F; Nunes de Almeida F; Afari S; Chhouri H; Vunjak-Novakovic G; Abate-Shen C
Oncogene; 2024 May; 43(21):1654. PubMed ID: 38627522
[No Abstract] [Full Text] [Related]
8. HIF-1α/Malat1/miR-141 Axis Activates Autophagy to Increase Proliferation, Migration, and Invasion in Triple-negative Breast Cancer.
Xu F; Hu Y; Gao J; Wang J; Xie Y; Sun F; Wang L; Miyamoto A; Xia O; Zhang C
Curr Cancer Drug Targets; 2023; 23(5):363-378. PubMed ID: 36579395
[TBL] [Abstract][Full Text] [Related]
9. Geiparvarin Inhibits the Progression of Osteosarcoma by Down-regulating COX2 Expression.
Wang B; Du J; Zhang Z; Huang P; Chen S; Zou H
Curr Cancer Drug Targets; 2023; 23(5):379-387. PubMed ID: 36503472
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial Application of Papain and CD66B for Isolating Glioma- Associated Neutrophils.
Xu X; Yang Y; Liu Y; Ge X; Yi T; Xie Y; Ning C; Shen S; Sun Z; Zhang Z; Zhai Q; Wang X; Meng X; Dong J; Huang Q; Yang X; Li W; Jin X
Curr Cancer Drug Targets; 2023; 23(5):400-411. PubMed ID: 36305130
[TBL] [Abstract][Full Text] [Related]
11. Polyphyllin VII as a Potential Drug for Targeting Stemness in Hepatocellular Cancer
Xu L; Chen Z; Wang Y; Li Y; Wang Z; Li F; Xi X
Curr Cancer Drug Targets; 2023; 23(4):325-331. PubMed ID: 36284387
[TBL] [Abstract][Full Text] [Related]
12. Combined Immunotherapy and Targeted Therapies for Cancer Treatment: Recent Advances and Future Perspectives.
Zhang Y; Li Y; Fu Q; Han Z; Wang D; Umar Shinge SA; Muluh TA; Lu X
Curr Cancer Drug Targets; 2023; 23(4):251-264. PubMed ID: 36278447
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of Core 1 Beta 1, 3-Galactosyltransferase Suppresses Osteosarcoma Growth with Induction of IFN-γ Secretion and Proliferation of CD8
Tang L; Cegang F; Zhao H; Wang B; Jia S; Chen H; Cai H
Curr Cancer Drug Targets; 2023; 23(4):265-277. PubMed ID: 36221889
[TBL] [Abstract][Full Text] [Related]
14. Phosphoserine Aminotransferase 1: A Metabolic Enzyme Target of Cancers.
Yang X; Li C; Chen Y
Curr Cancer Drug Targets; 2023; 23(3):171-186. PubMed ID: 36043756
[TBL] [Abstract][Full Text] [Related]
15. RON Receptor Tyrosine Kinase in Tumorigenic Stemness as a Therapeutic Target of Antibody-drug Conjugates for Eradication of Triple-negative Breast Cancer Stem Cells.
Suthe SR; Yao HP; Weng TH; Wang MH
Curr Cancer Drug Targets; 2023; 23(2):103-117. PubMed ID: 36028965
[TBL] [Abstract][Full Text] [Related]
16. Present and Future Prospects of the Anti-cancer Activities of Saikosaponins.
Xiao LX; Zhou HN; Jiao ZY
Curr Cancer Drug Targets; 2022; 23(1):2-14. PubMed ID: 35946101
[TBL] [Abstract][Full Text] [Related]
17. Visualizing the Nucleome Using the CRISPR-Cas9 System: From in vitro to in vivo.
Maloshenok LG; Abushinova GA; Ryazanova AY; Bruskin SA; Zherdeva VV
Biochemistry (Mosc); 2023 Jan; 88(Suppl 1):S123-S149. PubMed ID: 37069118
[TBL] [Abstract][Full Text] [Related]
18. Sintilimab Plus Modified FOLFIRINOX in Metastatic or Recurrent Pancreatic Cancer: The Randomized Phase II CISPD3 Trial.
Fu Q; Chen Y; Huang D; Guo C; Zhang X; Xiao W; Xue X; Zhang Q; Li X; Gao S; Que R; Shen Y; Wu J; Zhang M; Bai X; Liang T
Ann Surg Oncol; 2023 Aug; 30(8):5071-5080. PubMed ID: 37052821
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulation-a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system.
Strzelec M; Detka J; Mieszczak P; Sobocińska MK; Majka M
Front Immunol; 2023; 14():1127704. PubMed ID: 36969193
[TBL] [Abstract][Full Text] [Related]
20. Inducible CRISPRi-Based Operon Silencing and Selective in
Murphy BT; Wiepen JJ; He H; Pramanik AS; Peters JM; Stevenson B; Zückert WR
J Bacteriol; 2023 Feb; 205(2):e0046822. PubMed ID: 36719218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
